Bonesupport Holding AB (publ) (FRA:2B4)

Market Cap	1.15B
Revenue (ttm)	101.23M
Net Income (ttm)	13.74M
Shares Out	n/a
EPS (ttm)	0.21
PE Ratio	83.83
Forward PE	40.00
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10
Average Volume	113
Open	18.46
Previous Close	18.44
Day's Range	17.55 - 18.47
52-Week Range	17.28 - 39.42
Beta	n/a
RSI	36.38
Earnings Date	Feb 24, 2026

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute t...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 139
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2B4

Financial Performance

In 2024, Bonesupport Holding AB's revenue was 898.73 million, an increase of 52.05% compared to the previous year's 591.08 million. Earnings were 133.75 million, a decrease of -45.41%.

Financial numbers in SEK